Skip to main content

Table 2 Univariate analysis for overall survival of patients with nasopharyngeal carcinoma

From: Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma

Kaplan-Meier Survival Rate

    

Censored

 
  

Total

Dead

N

%

P-value

 

Overall

50

16

34

68.0

 

T

Negative

7

3

4

57.1

0.543

 

Positive

43

13

30

69.8

 

B

Negative

9

4

5

55.6

0.253

 

Positive

41

12

29

70.7

 

FDC

Negative

20

8

12

60.0

0.286

 

Positive

30

8

22

73.3

 

CD80*

Negative

40

16

24

60.0

0.025

 

Positive

10

0

10

100.0

 

CD86*

Negative

40

16

24

60.0

0.025

 

Positive

10

0

10

100.0

 

CD80/86*

Negative

39

16

23

59.0

0.017

 

Positive

11

0

11

100.0

 

HLA1DR

Negative

15

7

8

53.3

0.167

 

Positive

35

9

26

74.3

 

S100

Negative

20

7

13

65.0

0.654

 

Positive

30

9

21

70.0

 
  1. P-value by Log-rank test
  2. Follow-up time: from diagnosis date till death/2-15-2007
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us